What You Should Know
- The Partnership: BrightHeart, an AI-driven prenatal ultrasound company, has launched its B-Right AI Platform on GE HealthCare’s Voluson
Solution Store, the leading digital marketplace for women’s health ultrasound. - The Problem: Currently, 30% of congenital defects go undetected during prenatal screenings, often due to sonographer shortages and variable expertise.
- The Solution: BrightHeart’s platform acts as an “expert-level” co-pilot, providing real-time guidance to ensure scan completeness and accuracy. Clinical data shows it improves congenital heart disease (CHD) detection rates to >96%, effectively closing the skills gap in resource-constrained environments.
The “30% Gap” in Diagnostics
The statistics driving this partnership are sobering. Currently, more than 30% of congenital defects go undetected prenatally. The root cause isn’t necessarily technology; it’s expertise. The U.S. is facing a severe sonographer shortage, and the skill required to identify a complex heart defect on a grainy ultrasound image is immense. BrightHeart fills this gap by acting as an AI co-pilot.
- Guidance: It provides real-time support during the scan to ensure every anatomical view is captured.
- Validation: It flags potential errors or missing data before the patient leaves the table.
- Results: Clinical studies published in The Green Journal show the platform can improve Congenital Heart Disease (CHD) detection to >96%.
“We’re helping to democratize access to expert-level prenatal care,” said Cécile Dupont, CEO of BrightHeart. “Working closely with GE HealthCare allows us to deliver best-in-class AI tools exactly where clinicians need it.”
Integrating into the “Trusted Ecosystem”
For GE HealthCare, this move is about strengthening the Voluson ecosystem. By opening its “Solution Store” to third-party innovators like BrightHeart, GE ensures its hardware remains the central hub for women’s health.
“Making BrightHeart’s B‑Right AI Platform available through the Voluson Solution Store—the first digital marketplace for Women’s Health ultrasound—puts clinically validated AI directly into the hands of Voluson customers. It helps care teams perform more complete and consistent prenatal exams and supports significantly improved performance in congenital defect screening,” said Gerald Seifriedsberger, General Manager of Women’s Health Ultrasound at GE HealthCare.
